Another interesting anti-GBM agent is celecoxib (CELE), the selective cyclooxygenase-2 (COX-2) inhibitor, and its dimethyl-analog, 2,5-dimethylcelecoxib (DMC) [15]. This evidence concerns the gene PTGS2 and glioblastoma.